Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial

Abstract Objective To compare the outcomes of patients undergoing Retroperitoneal laparoscopic Radical nephrectomy (RLRN) and Transperitoneal laparoscopic Radical nephrectomy (TLRN). Methods A total of 120 patients with localized renal cell carcinoma were randomized into either RLRN or TLRN group. M...

Full description

Bibliographic Details
Main Authors: Junyao Liu, Bin Zhang, Peng Qi, Xiaowei Ren, Duo Zheng, Yang He, Xu Zheng, Zhongjin Yue, Ye Li, Ningqiang Yang, Zhiping Wang, Junsheng Bao, Junqiang Tian, Li Yang, Zhenxing Zhai, Lingjun Zuo, Zizhen Hou, Jiaji Wang, Wei Wang, Hong Chang, Junhai Ma, Yunxin Zhang, Zhichun Dong, Zhilong Dong, Ganping Zhong, Hui Cheng, Pengyuan Lei, Zhongming Li, GongJin Wu, Panfeng Shang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Urology
Subjects:
Online Access:https://doi.org/10.1186/s12894-023-01364-w
_version_ 1827326055908638720
author Junyao Liu
Bin Zhang
Peng Qi
Xiaowei Ren
Duo Zheng
Yang He
Xu Zheng
Zhongjin Yue
Ye Li
Ningqiang Yang
Zhiping Wang
Junsheng Bao
Junqiang Tian
Li Yang
Zhenxing Zhai
Lingjun Zuo
Zizhen Hou
Jiaji Wang
Wei Wang
Hong Chang
Junhai Ma
Yunxin Zhang
Zhichun Dong
Zhilong Dong
Ganping Zhong
Hui Cheng
Pengyuan Lei
Zhongming Li
GongJin Wu
Panfeng Shang
author_facet Junyao Liu
Bin Zhang
Peng Qi
Xiaowei Ren
Duo Zheng
Yang He
Xu Zheng
Zhongjin Yue
Ye Li
Ningqiang Yang
Zhiping Wang
Junsheng Bao
Junqiang Tian
Li Yang
Zhenxing Zhai
Lingjun Zuo
Zizhen Hou
Jiaji Wang
Wei Wang
Hong Chang
Junhai Ma
Yunxin Zhang
Zhichun Dong
Zhilong Dong
Ganping Zhong
Hui Cheng
Pengyuan Lei
Zhongming Li
GongJin Wu
Panfeng Shang
author_sort Junyao Liu
collection DOAJ
description Abstract Objective To compare the outcomes of patients undergoing Retroperitoneal laparoscopic Radical nephrectomy (RLRN) and Transperitoneal laparoscopic Radical nephrectomy (TLRN). Methods A total of 120 patients with localized renal cell carcinoma were randomized into either RLRN or TLRN group. Mainly by comparing the patient perioperative related data, surgical specimen integrity, pathological results and tumor results. Results Each group comprised 60 patients. The two group were equivalent in terms of perioperative and pathological outcomes. The mean integrity score was significantly lower in the RLRN group than TLRN group. With a median follow-up of 36.4 months after the operation, Kaplan–Meier survival analysis showed no significant difference between RLRN and TLRN in overall survival (89.8% vs. 88.5%; P = 0.898), recurrence-free survival (77.9% vs. 87.7%; P = 0.180), and cancer-specific survival (91.4% vs. 98.3%; P = 0.153). In clinical T2 subgroup, the recurrence rate and recurrence-free survival in the RLRN group was significantly worse than that in the TLRN group (43.2% vs. 76.7%, P = 0.046). Univariate and multivariate COX regression analysis showed that RLRN (HR: 3.35; 95%CI: 1.12–10.03; P = 0.030), male (HR: 4.01; 95%CI: 1.07–14.99; P = 0.039) and tumor size (HR: 1.23; 95%CI: 1.01–1.51; P = 0.042) were independent risk factor for recurrence-free survival. Conclusions Our study showed that although RLRN versus TLRN had roughly similar efficacy, TLRN outperformed RLRN in terms of surgical specimen integrity. TLRN was also significantly better than RLRN in controlling tumor recurrence for clinical T2 and above cases. Trial registration Chinese Clinical Trial Registry ( https://www.chictr.org.cn/showproj.html?proj=24400 ), identifier: ChiCTR1800014431, date: 13/01/2018.
first_indexed 2024-03-07T14:39:07Z
format Article
id doaj.art-c11a27ff07f64f009f9d357da503e5df
institution Directory Open Access Journal
issn 1471-2490
language English
last_indexed 2024-03-07T14:39:07Z
publishDate 2024-02-01
publisher BMC
record_format Article
series BMC Urology
spelling doaj.art-c11a27ff07f64f009f9d357da503e5df2024-03-05T20:28:43ZengBMCBMC Urology1471-24902024-02-0124111010.1186/s12894-023-01364-wTransperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trialJunyao Liu0Bin Zhang1Peng Qi2Xiaowei Ren3Duo Zheng4Yang He5Xu Zheng6Zhongjin Yue7Ye Li8Ningqiang Yang9Zhiping Wang10Junsheng Bao11Junqiang Tian12Li Yang13Zhenxing Zhai14Lingjun Zuo15Zizhen Hou16Jiaji Wang17Wei Wang18Hong Chang19Junhai Ma20Yunxin Zhang21Zhichun Dong22Zhilong Dong23Ganping Zhong24Hui Cheng25Pengyuan Lei26Zhongming Li27GongJin Wu28Panfeng Shang29Department of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalSchool of Public Health, Lanzhou UniversityDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Xigu Branch of Lanzhou University Second HospitalDepartment of Urology, Xigu Branch of Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalDepartment of Urology, Lanzhou University Second HospitalAbstract Objective To compare the outcomes of patients undergoing Retroperitoneal laparoscopic Radical nephrectomy (RLRN) and Transperitoneal laparoscopic Radical nephrectomy (TLRN). Methods A total of 120 patients with localized renal cell carcinoma were randomized into either RLRN or TLRN group. Mainly by comparing the patient perioperative related data, surgical specimen integrity, pathological results and tumor results. Results Each group comprised 60 patients. The two group were equivalent in terms of perioperative and pathological outcomes. The mean integrity score was significantly lower in the RLRN group than TLRN group. With a median follow-up of 36.4 months after the operation, Kaplan–Meier survival analysis showed no significant difference between RLRN and TLRN in overall survival (89.8% vs. 88.5%; P = 0.898), recurrence-free survival (77.9% vs. 87.7%; P = 0.180), and cancer-specific survival (91.4% vs. 98.3%; P = 0.153). In clinical T2 subgroup, the recurrence rate and recurrence-free survival in the RLRN group was significantly worse than that in the TLRN group (43.2% vs. 76.7%, P = 0.046). Univariate and multivariate COX regression analysis showed that RLRN (HR: 3.35; 95%CI: 1.12–10.03; P = 0.030), male (HR: 4.01; 95%CI: 1.07–14.99; P = 0.039) and tumor size (HR: 1.23; 95%CI: 1.01–1.51; P = 0.042) were independent risk factor for recurrence-free survival. Conclusions Our study showed that although RLRN versus TLRN had roughly similar efficacy, TLRN outperformed RLRN in terms of surgical specimen integrity. TLRN was also significantly better than RLRN in controlling tumor recurrence for clinical T2 and above cases. Trial registration Chinese Clinical Trial Registry ( https://www.chictr.org.cn/showproj.html?proj=24400 ), identifier: ChiCTR1800014431, date: 13/01/2018.https://doi.org/10.1186/s12894-023-01364-wRenal cell carcinomaRetroperitoneal approachTransperitoneal approachLaparoscopic radical nephrectomy
spellingShingle Junyao Liu
Bin Zhang
Peng Qi
Xiaowei Ren
Duo Zheng
Yang He
Xu Zheng
Zhongjin Yue
Ye Li
Ningqiang Yang
Zhiping Wang
Junsheng Bao
Junqiang Tian
Li Yang
Zhenxing Zhai
Lingjun Zuo
Zizhen Hou
Jiaji Wang
Wei Wang
Hong Chang
Junhai Ma
Yunxin Zhang
Zhichun Dong
Zhilong Dong
Ganping Zhong
Hui Cheng
Pengyuan Lei
Zhongming Li
GongJin Wu
Panfeng Shang
Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial
BMC Urology
Renal cell carcinoma
Retroperitoneal approach
Transperitoneal approach
Laparoscopic radical nephrectomy
title Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial
title_full Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial
title_fullStr Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial
title_full_unstemmed Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial
title_short Transperitoneal vs retroperitoneal laparoscopic radical nephrectomy: a double-arm, parallel-group randomized clinical trial
title_sort transperitoneal vs retroperitoneal laparoscopic radical nephrectomy a double arm parallel group randomized clinical trial
topic Renal cell carcinoma
Retroperitoneal approach
Transperitoneal approach
Laparoscopic radical nephrectomy
url https://doi.org/10.1186/s12894-023-01364-w
work_keys_str_mv AT junyaoliu transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT binzhang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT pengqi transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT xiaoweiren transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT duozheng transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT yanghe transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT xuzheng transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT zhongjinyue transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT yeli transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT ningqiangyang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT zhipingwang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT junshengbao transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT junqiangtian transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT liyang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT zhenxingzhai transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT lingjunzuo transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT zizhenhou transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT jiajiwang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT weiwang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT hongchang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT junhaima transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT yunxinzhang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT zhichundong transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT zhilongdong transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT ganpingzhong transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT huicheng transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT pengyuanlei transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT zhongmingli transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT gongjinwu transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial
AT panfengshang transperitonealvsretroperitoneallaparoscopicradicalnephrectomyadoublearmparallelgrouprandomizedclinicaltrial